Live Webinar

After the Vote: Healthcare Policy Outlook for Payers, Providers and Patients

Presented by Managed Healthcare Executive and Drug Topics

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
Publication|Articles|July 29, 2025

Formulary Watch Spotlights

  • Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)

Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)

Learn about a treatment for squamous cell carcinoma of the anal canal.